SCHEMBL4330403

SCHEMBL4330403

C[C@H](O)CN1CCCC1C(=O)OC(C)(C)C

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 1/20 0.42
ADORA2A P29274 1/20 0.42
ADORA2B P29275 1/20 0.42
ADORA1 P30542 1/20 0.42
HRH3 Q9Y5N1 3/20 0.39
HSD17B10 Q99714 1/20 0.36
CASP3 P42574 1/20 0.36
POLB P06746 1/20 0.36
PARP1 P09874 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.35
CNR1 P21554 1/20 0.35
CNR2 P34972 1/20 0.35
KLK5 Q9Y337 1/20 0.35
RAB9A P51151 1/20 0.35
KMT2A Q03164 2/20 0.34
MEN1 O00255 1/20 0.33
ALDH1A1 P00352 1/20 0.33
MAPT P10636 1/20 0.33
PEPD P12955 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4330401 1.00 ADORA3 (0.42) ADORA3ADORA2AADORA2BADORA1HRH3
SCHEMBL4330406 1.00 ADORA3 (0.42) ADORA3ADORA2AADORA2BADORA1HRH3
SCHEMBL4340694 1.00 ADORA3 (0.42) ADORA3ADORA2AADORA2BADORA1HRH3
SCHEMBL21340410 0.90 CNR1 (0.43) ADORA3ADORA2AADORA2BADORA1HRH3
SCHEMBL7432664 0.86 ADORA3 (0.41) ADORA3ADORA2AADORA2BADORA1HRH3
SCHEMBL6209278 0.81 HSD17B10 (0.40) ADORA3ADORA2AADORA2BADORA1HRH3
SCHEMBL7416557 0.81 HSD17B10 (0.40) ADORA3ADORA2AADORA2BADORA1HRH3
SCHEMBL2607025 0.81 HSD17B10 (0.40) ADORA3ADORA2AADORA2BADORA1HRH3
SCHEMBL27962888 0.81 HSD17B10 (0.40) ADORA3ADORA2AADORA2BADORA1HRH3
SCHEMBL27962887 0.81 HSD17B10 (0.40) ADORA3ADORA2AADORA2BADORA1HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7612068-B2 Aromatic oxyphenyl and aromatic sulfanylphenyl derivatives H. LUNDBECK A/S (DK) 2009-11-03 US disclosed
US-20060235003-A1 Aromatic oxyphenyl and aromatic sulfanylphenyl derivatives H. LUNDBECK A/S (DK) 2006-10-19 US disclosed
EP-1622868-A1 AROMATIC OXYPHENYL AND AROMATIC SULFANYLPHENYL DERIVATIVES H. LUNDBECK A/S (DK) 2006-02-08 EP disclosed
WO-2004096761-A1 AROMATIC OXYPHENYL AND AROMATIC SULFANYLPHENYL DERIVATIVES H. LUNDBECK A/S (DK) 2004-11-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060235003-A1 Aromatic oxyphenyl and aromatic sulfanylphenyl derivatives TYR, TPST2, COMT ADORA3 3015/4885ADORA2A 2955/4885ADORA2B 3468/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.